0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Dementia Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: October 2024
|
Report Code: QYRE-Auto-10Q5928
Home | Market Reports | Health| Aging & Geriatrics
Global Dementia Treatment Market Size Status and Forecast 2021 2027
BUY CHAPTERS

Dementia Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-10Q5928
Report
October 2024
Pages:83
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Dementia Treatment - Market Size

The global market for Dementia Treatment was estimated to be worth US$ 3640 million in 2023 and is forecast to a readjusted size of US$ 4384.5 million by 2030 with a CAGR of 2.8% during the forecast period 2024-2030

Dementia Treatment - Market

Dementia Treatment - Market

Donepezil (also known as Aricept), rivastigmine (Exelon) and galantamine (Reminyl) are used to treat the symptoms of mild to moderate Alzheimer's disease.
The Dementia Treatment market is driven by the aging global population and the subsequent increase in the prevalence of dementia-related disorders, such as Alzheimer's disease. As healthcare systems strive to address the growing burden of cognitive decline, research into effective treatments and interventions has intensified. Advancements in neuroscience and understanding of the underlying causes of dementia have led to the development of novel therapeutic approaches, including disease-modifying drugs and targeted interventions. However, challenges persist, such as the complexity of dementia etiology, the lack of a definitive cure, and the need for early and accurate diagnosis. Additionally, there is a need to enhance awareness, reduce stigma, and improve access to care and support services for both patients and caregivers. The Dementia Treatment market's potential can be harnessed by investing in research, promoting interdisciplinary collaborations, and tailoring treatment strategies to meet the diverse needs of patients across different stages of the disease.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Dementia Treatment, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Dementia Treatment by region & country, by Type, and by Application.
The Dementia Treatment market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dementia Treatment.
Market Segmentation

Scope of Dementia Treatment - Market Report

Report Metric Details
Report Name Dementia Treatment - Market
Forecasted market size in 2030 US$ 4384.5 million
CAGR 2.8%
Forecasted years 2024 - 2030
Segment by Type:
Segment by Application
  • Hospitals
  • Drugstores
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Allergan, Eisai, Novartis, Daiichi Sankyo, Merz Pharma, Pfizer, Johnson & Johnson, Lundbeck
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Dementia Treatment manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Dementia Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Dementia Treatment in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Dementia Treatment - Market size in 2030?

Ans: The Dementia Treatment - Market size in 2030 will be US$ 4384.5 million.

Who are the main players in the Dementia Treatment - Market report?

Ans: The main players in the Dementia Treatment - Market are Allergan, Eisai, Novartis, Daiichi Sankyo, Merz Pharma, Pfizer, Johnson & Johnson, Lundbeck

What are the Application segmentation covered in the Dementia Treatment - Market report?

Ans: The Applications covered in the Dementia Treatment - Market report are Hospitals, Drugstores, Others

What are the Type segmentation covered in the Dementia Treatment - Market report?

Ans: The Types covered in the Dementia Treatment - Market report are Donepezil, Memantine, Rivastigmine, Others

Recommended Reports

Alzheimer's Drugs & Diagnostics

Neurodegenerative Treatments

Cognitive & Mental Health

1 Market Overview
1.1 Dementia Treatment Product Introduction
1.2 Global Dementia Treatment Market Size Forecast
1.3 Dementia Treatment Market Trends & Drivers
1.3.1 Dementia Treatment Industry Trends
1.3.2 Dementia Treatment Market Drivers & Opportunity
1.3.3 Dementia Treatment Market Challenges
1.3.4 Dementia Treatment Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Dementia Treatment Players Revenue Ranking (2023)
2.2 Global Dementia Treatment Revenue by Company (2019-2024)
2.3 Key Companies Dementia Treatment Manufacturing Base Distribution and Headquarters
2.4 Key Companies Dementia Treatment Product Offered
2.5 Key Companies Time to Begin Mass Production of Dementia Treatment
2.6 Dementia Treatment Market Competitive Analysis
2.6.1 Dementia Treatment Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Dementia Treatment Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dementia Treatment as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Donepezil
3.1.2 Memantine
3.1.3 Rivastigmine
3.1.4 Others
3.2 Global Dementia Treatment Sales Value by Type
3.2.1 Global Dementia Treatment Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Dementia Treatment Sales Value, by Type (2019-2030)
3.2.3 Global Dementia Treatment Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Drugstores
4.1.3 Others
4.2 Global Dementia Treatment Sales Value by Application
4.2.1 Global Dementia Treatment Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Dementia Treatment Sales Value, by Application (2019-2030)
4.2.3 Global Dementia Treatment Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Dementia Treatment Sales Value by Region
5.1.1 Global Dementia Treatment Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Dementia Treatment Sales Value by Region (2019-2024)
5.1.3 Global Dementia Treatment Sales Value by Region (2025-2030)
5.1.4 Global Dementia Treatment Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Dementia Treatment Sales Value, 2019-2030
5.2.2 North America Dementia Treatment Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Dementia Treatment Sales Value, 2019-2030
5.3.2 Europe Dementia Treatment Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Dementia Treatment Sales Value, 2019-2030
5.4.2 Asia Pacific Dementia Treatment Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Dementia Treatment Sales Value, 2019-2030
5.5.2 South America Dementia Treatment Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Dementia Treatment Sales Value, 2019-2030
5.6.2 Middle East & Africa Dementia Treatment Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Dementia Treatment Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Dementia Treatment Sales Value
6.3 United States
6.3.1 United States Dementia Treatment Sales Value, 2019-2030
6.3.2 United States Dementia Treatment Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Dementia Treatment Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Dementia Treatment Sales Value, 2019-2030
6.4.2 Europe Dementia Treatment Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Dementia Treatment Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Dementia Treatment Sales Value, 2019-2030
6.5.2 China Dementia Treatment Sales Value by Type (%), 2023 VS 2030
6.5.3 China Dementia Treatment Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Dementia Treatment Sales Value, 2019-2030
6.6.2 Japan Dementia Treatment Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Dementia Treatment Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Dementia Treatment Sales Value, 2019-2030
6.7.2 South Korea Dementia Treatment Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Dementia Treatment Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Dementia Treatment Sales Value, 2019-2030
6.8.2 Southeast Asia Dementia Treatment Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Dementia Treatment Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Dementia Treatment Sales Value, 2019-2030
6.9.2 India Dementia Treatment Sales Value by Type (%), 2023 VS 2030
6.9.3 India Dementia Treatment Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Allergan
7.1.1 Allergan Profile
7.1.2 Allergan Main Business
7.1.3 Allergan Dementia Treatment Products, Services and Solutions
7.1.4 Allergan Dementia Treatment Revenue (US$ Million) & (2019-2024)
7.1.5 Allergan Recent Developments
7.2 Eisai
7.2.1 Eisai Profile
7.2.2 Eisai Main Business
7.2.3 Eisai Dementia Treatment Products, Services and Solutions
7.2.4 Eisai Dementia Treatment Revenue (US$ Million) & (2019-2024)
7.2.5 Eisai Recent Developments
7.3 Novartis
7.3.1 Novartis Profile
7.3.2 Novartis Main Business
7.3.3 Novartis Dementia Treatment Products, Services and Solutions
7.3.4 Novartis Dementia Treatment Revenue (US$ Million) & (2019-2024)
7.3.5 Daiichi Sankyo Recent Developments
7.4 Daiichi Sankyo
7.4.1 Daiichi Sankyo Profile
7.4.2 Daiichi Sankyo Main Business
7.4.3 Daiichi Sankyo Dementia Treatment Products, Services and Solutions
7.4.4 Daiichi Sankyo Dementia Treatment Revenue (US$ Million) & (2019-2024)
7.4.5 Daiichi Sankyo Recent Developments
7.5 Merz Pharma
7.5.1 Merz Pharma Profile
7.5.2 Merz Pharma Main Business
7.5.3 Merz Pharma Dementia Treatment Products, Services and Solutions
7.5.4 Merz Pharma Dementia Treatment Revenue (US$ Million) & (2019-2024)
7.5.5 Merz Pharma Recent Developments
7.6 Pfizer
7.6.1 Pfizer Profile
7.6.2 Pfizer Main Business
7.6.3 Pfizer Dementia Treatment Products, Services and Solutions
7.6.4 Pfizer Dementia Treatment Revenue (US$ Million) & (2019-2024)
7.6.5 Pfizer Recent Developments
7.7 Johnson & Johnson
7.7.1 Johnson & Johnson Profile
7.7.2 Johnson & Johnson Main Business
7.7.3 Johnson & Johnson Dementia Treatment Products, Services and Solutions
7.7.4 Johnson & Johnson Dementia Treatment Revenue (US$ Million) & (2019-2024)
7.7.5 Johnson & Johnson Recent Developments
7.8 Lundbeck
7.8.1 Lundbeck Profile
7.8.2 Lundbeck Main Business
7.8.3 Lundbeck Dementia Treatment Products, Services and Solutions
7.8.4 Lundbeck Dementia Treatment Revenue (US$ Million) & (2019-2024)
7.8.5 Lundbeck Recent Developments
8 Industry Chain Analysis
8.1 Dementia Treatment Industrial Chain
8.2 Dementia Treatment Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Dementia Treatment Sales Model
8.5.2 Sales Channel
8.5.3 Dementia Treatment Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Dementia Treatment Market Trends
    Table 2. Dementia Treatment Market Drivers & Opportunity
    Table 3. Dementia Treatment Market Challenges
    Table 4. Dementia Treatment Market Restraints
    Table 5. Global Dementia Treatment Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Dementia Treatment Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Dementia Treatment Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Dementia Treatment Product Type
    Table 9. Key Companies Time to Begin Mass Production of Dementia Treatment
    Table 10. Global Dementia Treatment Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dementia Treatment as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Dementia Treatment Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Dementia Treatment Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Dementia Treatment Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Dementia Treatment Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Dementia Treatment Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Dementia Treatment Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Dementia Treatment Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Dementia Treatment Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Dementia Treatment Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Dementia Treatment Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Dementia Treatment Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Dementia Treatment Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Dementia Treatment Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Dementia Treatment Sales Value by Region (2019-2024) & (%)
    Table 27. Global Dementia Treatment Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Dementia Treatment Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Dementia Treatment Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Dementia Treatment Sales Value, (2025-2030) & (US$ Million)
    Table 31. Allergan Basic Information List
    Table 32. Allergan Description and Business Overview
    Table 33. Allergan Dementia Treatment Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Dementia Treatment Business of Allergan (2019-2024)
    Table 35. Allergan Recent Developments
    Table 36. Eisai Basic Information List
    Table 37. Eisai Description and Business Overview
    Table 38. Eisai Dementia Treatment Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Dementia Treatment Business of Eisai (2019-2024)
    Table 40. Eisai Recent Developments
    Table 41. Novartis Basic Information List
    Table 42. Novartis Description and Business Overview
    Table 43. Novartis Dementia Treatment Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Dementia Treatment Business of Novartis (2019-2024)
    Table 45. Novartis Recent Developments
    Table 46. Daiichi Sankyo Basic Information List
    Table 47. Daiichi Sankyo Description and Business Overview
    Table 48. Daiichi Sankyo Dementia Treatment Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Dementia Treatment Business of Daiichi Sankyo (2019-2024)
    Table 50. Daiichi Sankyo Recent Developments
    Table 51. Merz Pharma Basic Information List
    Table 52. Merz Pharma Description and Business Overview
    Table 53. Merz Pharma Dementia Treatment Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Dementia Treatment Business of Merz Pharma (2019-2024)
    Table 55. Merz Pharma Recent Developments
    Table 56. Pfizer Basic Information List
    Table 57. Pfizer Description and Business Overview
    Table 58. Pfizer Dementia Treatment Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Dementia Treatment Business of Pfizer (2019-2024)
    Table 60. Pfizer Recent Developments
    Table 61. Johnson & Johnson Basic Information List
    Table 62. Johnson & Johnson Description and Business Overview
    Table 63. Johnson & Johnson Dementia Treatment Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Dementia Treatment Business of Johnson & Johnson (2019-2024)
    Table 65. Johnson & Johnson Recent Developments
    Table 66. Lundbeck Basic Information List
    Table 67. Lundbeck Description and Business Overview
    Table 68. Lundbeck Dementia Treatment Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Dementia Treatment Business of Lundbeck (2019-2024)
    Table 70. Lundbeck Recent Developments
    Table 71. Key Raw Materials Lists
    Table 72. Raw Materials Key Suppliers Lists
    Table 73. Dementia Treatment Downstream Customers
    Table 74. Dementia Treatment Distributors List
    Table 75. Research Programs/Design for This Report
    Table 76. Key Data Information from Secondary Sources
    Table 77. Key Data Information from Primary Sources
    Table 78. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Dementia Treatment Product Picture
    Figure 2. Global Dementia Treatment Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Dementia Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 4. Dementia Treatment Report Years Considered
    Figure 5. Global Dementia Treatment Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Dementia Treatment Revenue in 2023
    Figure 7. Dementia Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Donepezil Picture
    Figure 9. Memantine Picture
    Figure 10. Rivastigmine Picture
    Figure 11. Others Picture
    Figure 12. Global Dementia Treatment Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 13. Global Dementia Treatment Sales Value Market Share by Type, 2023 & 2030
    Figure 14. Product Picture of Hospitals
    Figure 15. Product Picture of Drugstores
    Figure 16. Product Picture of Others
    Figure 17. Global Dementia Treatment Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 18. Global Dementia Treatment Sales Value Market Share by Application, 2023 & 2030
    Figure 19. North America Dementia Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 20. North America Dementia Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 21. Europe Dementia Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 22. Europe Dementia Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 23. Asia Pacific Dementia Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 24. Asia Pacific Dementia Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 25. South America Dementia Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 26. South America Dementia Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 27. Middle East & Africa Dementia Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 28. Middle East & Africa Dementia Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 29. Key Countries/Regions Dementia Treatment Sales Value (%), (2019-2030)
    Figure 30. United States Dementia Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 31. United States Dementia Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 32. United States Dementia Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 33. Europe Dementia Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 34. Europe Dementia Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 35. Europe Dementia Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 36. China Dementia Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 37. China Dementia Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 38. China Dementia Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 39. Japan Dementia Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 40. Japan Dementia Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 41. Japan Dementia Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 42. South Korea Dementia Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 43. South Korea Dementia Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 44. South Korea Dementia Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 45. Southeast Asia Dementia Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 46. Southeast Asia Dementia Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 47. Southeast Asia Dementia Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 48. India Dementia Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 49. India Dementia Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 50. India Dementia Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 51. Dementia Treatment Industrial Chain
    Figure 52. Dementia Treatment Manufacturing Cost Structure
    Figure 53. Channels of Distribution (Direct Sales, and Distribution)
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI